Emergence of colistin resistance in the largest university hospital complex of São Paulo, Brazil, over five years

Brazilian Journal of Infectious Diseases

Volumn 21, Issue 1, 2017, Pages 98-101

  Rossi, Flávia ^a   Girardello, Raquel ^a   Cury, Ana Paula ^a   Di Gioia, Thais Sabato Romano ^a   Almeida, João Nóbrega de ^a   Duarte, Alberto José da Silva ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Brazil; Colistin resistant; Enterobacteriaceae; Polymyxin B resistant

Indexed keywords

CARBAPENEM; COLISTIN; ANTIINFECTIVE AGENT;

ACINETOBACTER; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BRAZIL; BROTH DILUTION; ENTEROBACTERIACEAE; EPSILOMETER TEST; GRAM NEGATIVE BACTERIUM; KLEBSIELLA PNEUMONIAE; MIC50; MIC90; MULTIDRUG RESISTANCE; NONHUMAN; PSEUDOMONAS; TEMPORAL ANALYSIS; UNIVERSITY HOSPITAL; DRUG EFFECTS; HUMAN; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; RETROSPECTIVE STUDY; TIME FACTOR;

ACINETOBACTER; ANTI-BACTERIAL AGENTS; BRAZIL; COLISTIN; DRUG RESISTANCE, BACTERIAL; ENTEROBACTERIACEAE; HOSPITALS, UNIVERSITY; HUMANS; MICROBIAL SENSITIVITY TESTS; PSEUDOMONAS; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 85008178872     PISSN: 14138670     EISSN: 16784391     Source Type: Journal    
DOI: 10.1016/j.bjid.2016.09.011     Document Type: Article

References (20)

1. 1 Brazilian Health Surveillance Agency (ANVISA). Boletim Informativo: Segurança e qualidade em serviço de saúde n° 9: Relatório da resistência microbiana em infecções primárias de corrente sanguínea confirmadas laboratorialmente relacionadas ao uso de cateter venoso central em unidades de terapia intensiva. Available from: http://portal.anvisa.gov.br/wps/content/Anvisa+Portal/Anvisa/Inicio/Servicos+de+Saude/Assunto+de+Interesse/Boletim+Seguranca+do+Paciente/Seguranca+e+qualidade+em+servico+de+saude+n+9; 2013 [accessed 03.01.15].
2. 2 Yau, W., Owen, R.J., Poudyal, A., et al. Colistin hetero-resistance in multidrug-resistant Acinetobacter baumannii clinical isolates from the Western Pacific region in the SENTRY antimicrobial surveillance programme. J Infect 58 (2009), 138–144.
3. 3 Gales, A.C., Castanheira, M., Jones, R.N., Sader, H.S., Antimicrobial resistance among Gram-negative bacilli isolated from Latin America: results from SENTRY Antimicrobial Surveillance Program (Latin America, 2008–2010). Diagn Microbiol Infect Dis 73 (2012), 354–360.
4. 4 Sader, H.S., Farrell, D.J., Flamm, R.K., Jones, R.N., Antimicrobial susceptibility of Gram-negative organisms isolated from patients hospitalized in intensive care units in United States and European hospitals (2009–2011). Diagn Microbiol Infect Dis 78 (2014), 443–448.
5. 5 Dias, V.C., Diniz, C.G., Peter, A.C., et al. Epidemiological characteristics and antimicrobial susceptibility among carbapenem-resistant non-fermenting bacteria in Brazil. J Infect Dev Ctries 10 (2016), 544–553.
6. 6 Abboud, C.S., Monteiro, J., Stryjewski, M.E., et al. Post-surgical mediastinitis due to carbapenem-resistant Enterobacteriaceae: clinical, epidemiological and survival characteristics. Int J Antimicrob Agents 47 (2016), 386–390.
7. 7 CLSI, Clinical Laboratory Standard Institute, Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard. Ninth ed., 2012 Document M07-A9. Wayne, PA.
8. 8 CLSI, Clinical Laboratory Standard Institute, Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Six Informational Supplement. Document M100-S26, Wayne, PA. 2016.
9. 9 European Committee on Antimicrobial Susceptibility Testing. Breakpoint interpretation of MICs and zone diameters, Version 4.0. 2016.
10. 10 Hawley, J.S., Murray, C.K., Jorgensen, J.H., Colistin heteroresistance in Acinetobacter and its association with previous colistin therapy. Antimicrob Agents Chemother 52 (2008), 351–352.
11. 11 Giani, T., Arena, F., Vaggelli, G., et al. Large nosocomial outbreak of colistin-resistant, carbapenemase-producing Klebsiella pneumoniae traced to clonal expansion of an mgrB deletion mutant. J Clin Microbiol 53 (2015), 3341–3344.
12. 12 Gales, A.C., Jones, R.N., Sader, H.S., Contemporary activity of colistin and polymyxin B against a worldwide collection of Gram-negative pathogens: results from the SENTRY Antimicrobial Surveillance Program (2006–09). J Antimicrob Chemother 66 (2011), 2070–2074.
13. 13 Monteiro, J., Santos, A.F., Asensi, M.D., Peirano, G., Gales, A.C., First report of KPC-2-producing Klebsiella pneumoniae strains in Brazil. Antimicrob Agents Chemother 53 (2009), 333–334.
14. 14 Zavascki, A.P., Machado, A.B., de Oliveira, K.R., et al. KPC-2-producing Enterobactercloacae in two cities from Southern Brazil. Int J Antimicrob Agents 34 (2009), 286–288.
15. 15 Jácome, P.R., Alves, L.R., Cabral, A.B., Lopes, A.C., Maciel, M.A., First report of KPC-producing Pseudomonas aeruginosa in Brazil. Antimicrob Agents Chemother, 56, 2012, 4990.
16. 16 Rizek, C., Fu, L., Dos Santos, L.C., et al. Characterization of carbapenem-resistant Pseudomonas aeruginosa clinical isolates, carrying multiple genes coding for this antibiotic resistance. Ann Clin Microbiol Antimicrob, 13, 2014, 43.
17. 17 Provasi Cardoso, J., Cayô, R., Girardello, R., Gales, A.C., Diversity of mechanisms conferring resistance to β-lactams among OXA-23-producing Acinetobacter baumannii clones. Diagn Microbiol Infect Dis 85 (2016), 90–97.
18. 18 Santana Rde, C., Gaspar, G.G., Vilar, F.C., Bellissimo-Rodrigues, F., Martinez, R., Secular trends in Klebsiella pneumoniae isolated in a tertiary-care hospital: increasing prevalence and accelerated decline in antimicrobial susceptibility. Rev Soc Bras Med Trop 49 (2016), 177–182.
19. 19 Olaitan, A.O., Morand, S., Rolain, J.M., Emergence of colistin-resistant bacteria in humans without colistin usage: a new worry and cause for vigilance. Int J Antimicrob Agents 47 (2016), 1–3.
20. 20 Girardello, R., Bispo, P.J., Yamanaka, T.M., Gales, A.C., Cation concentration variability of four distinct Mueller-Hinton agar brands influences polymyxin B susceptibility results. J Clin Microbiol 50 (2012), 2414–2418.